GERMANY - BSN Medical buyout approved by EU

following the successful completion of the sale, BSN medical will operate as a fully independent player in the wound care, non-invasive orthopaedics and phlebology segments, each of which are markets characterized by above-average growth rates. The management team of BSN will be supported by Montagu in realizing its growth strategy.

The transaction paves the way for a sustained future course of growth. Since the company was established as a joint venture in 2001, it has advanced to become one of the world’s leading suppliers in the casting and bandaging, traditional wound care and compression stocking product segments. The independence of the company will enable it to focus yet more closely on the ongoing development of its core business in the field of professional medical products, most notably through an addition of innovative new lines to the product portfolio and through the expansion of the international distribution network.

With its experienced management, dedicated workforce, a high quality product portfolio and a proven track record for potentials in the field of innovation, BSN medical has a great platform from which to accelerate the company’s further development in form of strategic acquisitions. Licensing agreements and the bolt-on of both innovative products and technologies are planned in order to give a broader international base to the existing product know-how. Moreover, efforts are to be made to access new geographical markets for instance in Asia and Latin America and to boost sales in existing markets through enhanced marketing and distribution activities.

On completing the transaction, Graham Siddle, CEO of BSN medical, said: 'In recent years, BSN has carved out an excellent position for itself in the marketplace, and we shall, as an independent company, seek to leverage this position by adding new products. This will open up further channels for development for BSN and our employees.'

Nico Helling, director of Montagu, added: 'We will support the growth strategy of BSN medical financially and back the company in strategic acquisitions for which we have committed solid capital resources.'

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Buyouts
• DACH